Search Orphan Drug Designations and Approvals
-
Generic Name: | 4-[[[4-(4-Chlorophenoxy)phenyl]sulfonyl]-methyl] tetrahydro-N-hydroxy-2H-pyran-4-carboxamide |
---|---|
Date Designated: | 06/18/2008 |
Orphan Designation: | Prophylaxis of organ rejection in patients receiving allogeneic liver transplants |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Conatus Pharmaceuticals, Inc. 4365 Executive Drive San Diego, California 92121 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-